FROSCH Stefanie,FROSCH Stefanie,LINZ Klaus,LINZ Klaus,SCHIENE Klaus,SCHIENE Klaus
申请号：
SI201330919
公开号：
SI2849746T1
申请日:
2013.05.16
申请国别(地区):
SI
年份:
2018
代理人:
摘要：
The invention relates to a pharmaceutical composition comprising a first pharmacologically active ingredient, which is selected from (1r,4r)-6&prime-fluoro-N,N-dimethyl-4-phenyl-4&prime,9&prime-dihydro-3&primeH-spiro[cyclohexane-1,1&prime-pyrano[3,4,b]indol]-4-amine and the physiologically acceptable salts thereof, and a second pharmacologically active ingredient, which is an oxicam selected from the group consisting of meloxicam, piroxicam, tenoxicam, lornoxicam, droxicam and the physiologically acceptable salts thereof.
